×
Health / Pharamceutical

Sanofi and Translate Bio mRNA COVID-19 Vaccine Candidate Induced High Antibody Levels in Preclinical Studies

Published Oct 15 2020 at 12:10 AM GMT
Drugs.com

Drugs.com @drugs.com

Continue reading at drugs.com
Key
Points
  • – October 15, 2020 - Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio (NASDAQ: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company, today announced the preclinical.
Credit
Tags
Continue reading at drugs.com
Trending

Stats

  • Published Oct 15, 2020 12:10 AM GMT